Diagnosing CAPS can be challenging due to its rarity and overlapping symptoms with other disorders. A clinical diagnosis is often supported by a combination of genetic testing, patient history, and physical examinations. Elevated inflammatory markers like C-reactive protein (CRP) and serum amyloid A (SAA) may also be present. A definitive diagnosis usually involves identifying mutations in the NLRP3 gene through genetic testing.
